期刊文献+

乙肝肝硬化患者生活质量相关因素分析 被引量:14

Factors associated with health-related quality of life in patients with liver cirrhosis
暂未订购
导出
摘要 目的:探讨乙型病毒性肝炎肝硬化患者健康相关生活质量,并分析其影响因素。方法:采用简明生命质量测定量表(SF-36)中文版对120例乙肝肝硬化患者的生活质量进行测量,对其影响因素进行单因素分析和多因素logistic回归分析,并与正常人群进行对比。结果:除心理功能维度外,肝硬化患者生活质量各维度均低于对照组(P<0.001);Child分级主要影响生理健康方面的评分,而性别对生理及心理健康方面评分均有影响。结论:肝硬化患者生活质量普遍下降,其主要影响因素为性别与Child分级。 Objective: To explore factors associated with health-related quality of life (HRQOL) in patients with HBV-related liver cirrhosis. Methods: A cross-sectional study in which 120 patients' demographic and clinical characteristics were documented and their HRQOL was conducted by using the Chinese version of Short Form-36. The association of HRQOL impairment with clinical parameters was compared between patients and normal persons by univariate analysis and multiple logistic stepwise regression. Results: In all except one domains (mental health) of SF-36, HRQOL scores were significantly lower in the patient group than in the control group ( P 〈 0.001 ) ; Child class was mainly associated with score in Physical Component Summary (PCS) while gender affected both PCS and Mental Component Summary (MCS) score. Conclusion: HRQOL of patients with liver cirrhosis is impaired obviously. The score is further affected by gender and Child class.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第9期885-888,共4页 Journal of Shandong University:Health Sciences
关键词 肝硬化 肝炎病毒 乙型 生活质量 SF-36 Liver cirrhosis Hepatitis B virus Quality of life SF-36
  • 相关文献

参考文献4

二级参考文献44

  • 1国家统计局人口与就业司.中国人口统计年鉴[M].北京:中国统计出版社,1997.4-6.
  • 2[1]Hwang SJ.Hepatitis C virus infection:an overview.J Microbiol Immunol Infect 2001;34:227-234
  • 3[2]Seeff LB.The natural history of chronic hepatitis C virus infection.Clin Liver Dis 1997;1:587-602
  • 4[3]Lu SN,Chue PY,Chen IL,Wang JH,Huang JF,Peng CF,Shih CH,Chang WY.Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan.Kaohsiung J Med Sci 1997;13:605-608
  • 5[4]Lin CC,Hwang SJ,Chiou ST,Kuan CL,Chen LW,Lee TC,Lee MB,Lee HH,Hsu PS,Tsai ST.The prevalence and risk factors analysis of serum antibody to hepatitis C virus in the elders in northeast Taiwan.J Chin Med Assoc 2003;66:103-108
  • 6[5]Hwang SJ,Lee SD,Chan CY,Lu RH,Chang FY.A randomized,double blind,controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.Am J Gastroenterol 1999;94:2496-2500
  • 7[6]Hwang SJ,Lee SD,Chu CW,Lu RH,Chang FY.An open-label trial of consensus interferon 15 μg in the treatment of Chinese patients with chronic hepatitis C.Hepatol Res 2001;19:284-293
  • 8[7]Hwang SJ,Chan CY,Lu RH,Wu JC,Lee SD.Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.J Interferon Cytokine Res 1995;15:611-616
  • 9[8]Lai MY,Kao JH,Yang PM,Wang JT,Chen PJ,Chan KW,Chu JS,Chen DS.Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.Gastroenterology 1996;111:1307-1312
  • 10[9]Ware JE Jr.John E.Ware Jr.on health status and quality of life assessment and the next generation of outcomes measurement.Interview by Marcia Stevic and Katie Berry.J Healthc Qual 1999;21:12-17

共引文献607

同被引文献114

引证文献14

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部